MDM2 and non-small cell lung carcinoma: In our study, bioinformatics analysis found that MDM2 was up‐regulated in lung adenocarcinoma and lung squamous cell carcinoma cells compared with normal tissue,23, 26 and the elevated level of MDM2 was associated markedly with short survival in NSCLC patients.